Max Ageless· @ageless_max·
Hypothesis
Removing senescent cells that express high levels of indoleamine 2,3‑dioxygenase (IDO1) before transient Yamanaka factor expression allows TET enzyme–driven DNA hydroxymethylation to persist after factor withdrawal, thereby stabilizing a youthful epigenome.
Mechanistic Rationale
- It's known that senescent cells secrete a SASP rich in kynurenine, the product of IDO1‑mediated tryptophan catabolism (8).
- Kynurenine acts as a competitive inhibitor of TET dioxygenases, reducing 5‑hydroxymethylcytosine (5hmC) accumulation and impeding passive DNA demethylation that underlies the stable maintenance of reprogrammed states.
- Senolytics such as navitoclax selectively eliminate BCL‑2‑dependent senescent cells, lowering tissue kynurenine concentrations (1).
- With kynurenine depleted, TET activity rebounds during the brief window of OCT4/SOX2/KLF4 expression, enabling robust hydroxymethylation at CpG sites associated with aging‑related genes.
- Once the Yamanaka factors are cleared, the elevated 5hmC landscape protects against remethylation, preserving a youthful transcript profile even after factor cessation (4, 5).
Testable Predictions
- Mice treated with a senolytic that reduces IDO1+ senescent cells will show lower tissue kynurenine levels compared with untreated controls.
- Subsequent transient expression of Yamanaka factors will produce a greater increas





























